Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation

被引:178
作者
Amrolia, Persis J.
Muccioli-Casadei, Giada
Huls, Helen
Adams, Stuart
Durett, April
Gee, Adrian
Yvon, Eric
Weiss, Heidi
Cobbold, Mark
Gaspar, H. Bobby
Rooney, Cliona
Kuehnle, Ingrid
Ghetie, Victor
Schindler, John
Krance, Robert
Heslop, Helen E.
Veys, Paul
Vitetta, Ellen
Brenner, Malcolm K.
机构
[1] Great Ormond St Hosp Sick Children, Dept Bone Marrow Transplantat, London WC1N 3JH, England
[2] Great Ormond St Hosp Sick Children, Dept Immunol, London WC1N 3JH, England
[3] Univ Texas, SW Med Sch, Ctr Canc Immunobiol, Dallas, TX 75230 USA
[4] Univ Birmingham, Inst Canc Studies, Canc Res United Kingdom, Birmingham, W Midlands, England
[5] Univ Naples Federico 2, CEINGE Biotechnol Avanzale, Naples, Italy
[6] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, Naples, Italy
[7] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA
基金
英国医学研究理事会;
关键词
D O I
10.1182/blood-2006-02-001909
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Poor T lymphocyte reconstitution limits the use of haploidentical stem cell transplantation (SCT) because it results in a high mortality from viral infections. One approach to overcome this problem is to infuse donor T cells from which alloreactive lymphocytes have been selectively depleted, but the immunologic benefit of this approach is unknown. We have used an anti-CD25 immunotoxin to deplete alloreactive lymphocytes and have compared immune reconstitution after allodepleted donor T cells were infused at 2 dose levels into recipients of T-cell-depleted haploidentical SCT. Eight patients were treated at 10(4) cells/kg/dose, and 8 patients received 10(5) cells/kg/dose. Patients receiving 10(5) cells/kg/dose showed significantly improved T-cell recovery at 3, 4, and 5 months after SCT compared with those receiving 10(4) cells/kg/dose (P < .05). Accelerated T-cell recovery occurred as a result of expansion of the effector memory (CD45RA(-)CCR-7(-)) population (P < .05), suggesting that protective T-cell responses are likely to be long lived. T-cell-receptor signal joint excision circles (TRECs) were not detected in reconstituting T cells in dose-level 2 patients, indicating they are likely to be derived from the infused allodepleted cells. Spectratyping of the T cells at 4 months demonstrated a polyclonal V beta repertoire. Using tetramer and enzyme-linked immunospot (ELISPOT) assays, we have observed cytomegalovirus (CMV)-and Epstein-Barr virus (EBV)-specific responses in 4 of 6 evaluable patients at dose level 2 as early as 2 to 4 months after transplantation, whereas such responses were not observed until 6 to 12 months in dose-level 1 patients. The incidence of significant acute (2 of 16) and chronic graft-versus-host disease (GVHD; 2 of 15) was low. These data demonstrate that allodepleted donor T cells can be safely used to improve T-cell recovery after haploidentical SCT and may broaden the applicability of this approach.
引用
收藏
页码:1797 / 1808
页数:12
相关论文
共 45 条
  • [1] Selective depletion of donor alloreactive T cells without loss of antiviral or antileukernic responses
    Amrolia, PJ
    Muccioli-Casadei, G
    Yvon, E
    Huls, H
    Sili, U
    Wieder, ED
    Bollard, C
    Heslop, HE
    Molldrem, JJ
    Rooney, CM
    Brenner, MK
    [J]. BLOOD, 2003, 102 (06) : 2292 - 2299
  • [2] Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation:: a phase 1/2 study
    André-Schmutz, I
    Le Deist, F
    Hacein-Bey-Abina, S
    Vitetta, E
    Schindler, J
    Chedeville, G
    Vilmer, E
    Fischer, A
    Cavazzana-Calvo, M
    [J]. LANCET, 2002, 360 (9327) : 130 - 137
  • [3] Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
    Aversa, F
    Tabilio, A
    Velardi, A
    Cunningham, I
    Terenzi, A
    Falzetti, F
    Ruggeri, L
    Barbabietola, G
    Aristei, C
    Latini, P
    Reisner, Y
    Martelli, MF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (17) : 1186 - 1193
  • [4] Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse
    Aversa, F
    Terenzi, A
    Tabilio, A
    Falzetti, F
    Carotti, A
    Ballanti, S
    Felicini, R
    Falcinelli, F
    Velardi, A
    Ruggeri, L
    Aloisi, T
    Saab, JP
    Santucci, A
    Perruccio, K
    Martelli, MP
    Mecucci, C
    Reisner, Y
    Martelli, MF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3447 - 3454
  • [5] HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
    Bonini, C
    Ferrari, G
    Verzeletti, S
    Servida, P
    Zappone, E
    Ruggieri, L
    Ponzoni, M
    Rossini, S
    Mavilio, F
    Traversari, C
    Bordignon, C
    [J]. SCIENCE, 1997, 276 (5319) : 1719 - 1724
  • [6] Cavazzana-Calvo Marina, 2001, Journal de la Societe de Biologie, V195, P65
  • [7] Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation
    Chakrabarti, S
    Milligan, DW
    Pillay, D
    Mackinnon, S
    Holder, K
    Kaur, N
    McDonald, D
    Fegan, CD
    Waldmann, H
    Hale, G
    Rickinson, A
    Steven, N
    [J]. BLOOD, 2003, 102 (03) : 839 - 842
  • [8] Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process
    Chen, BJ
    Cui, XY
    Liu, CX
    Chao, NJ
    [J]. BLOOD, 2002, 99 (09) : 3083 - 3088
  • [9] Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients
    Chen, XH
    Barfield, R
    Benaim, E
    Leung, W
    Knowles, J
    Lawrence, D
    Otto, M
    Shurtleff, SA
    Neale, GAM
    Behm, FG
    Turner, V
    Handgretinger, R
    [J]. BLOOD, 2005, 105 (02) : 886 - 893
  • [10] Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings
    Davies, JK
    Koh, MBC
    Lowdell, MW
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (04) : 259 - 268